Chinese Medical Isotope Diagnosis and Treatment Firm Raises $16M Fresh Funds

New Radiomedicine, a Chinese medical isotope diagnosis and treatment company, announced on Tuesday that it has raised RMB116 million (US$16.87 million) in a series B round of financing led by BTG International Asia Limited, a subsidiary of London-listed specialist healthcare company BTG plc.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in